Bridgewater Associates »

Adma Biologics shares owned by Bridgewater Associates

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Bridgewater Associates from 13F filings

Historical chart of Bridgewater Associates investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Bridgewater Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.4M 187k 18.24
2025-09-30 $884k 60k 14.66

More positions owned by Bridgewater Associates

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Lam Research Corp Com New (LRCX)
salesforce (CRM)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Adobe Systems Incorporated (ADBE)
Ge Vernova (GEV)
Booking Holdings (BKNG)
Broadcom (AVGO)
Oracle Corporation (ORCL)
Advanced Micro Devices (AMD)
Johnson & Johnson (JNJ)

View all positions for Bridgewater Associates

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Westfield Capital Management Company
Capital Research Global Investors
Nuveen
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
UBS Group
Thrivent Financial for Lutherans
Citadel Advisors
Caligan Partners

View all funds holding Adma Biologics